TVRD
Tvardi Therapeutics, Inc.
NASDAQ: TVRD · HEALTHCARE · BIOTECHNOLOGY
$3.15
+2.94% today
Updated 2026-04-30
Market cap
$30.02M
P/E ratio
—
P/S ratio
559.61x
EPS (TTM)
$-3.26
Dividend yield
—
52W range
$3 – $44
Volume
0.0M
Tvardi Therapeutics, Inc. (TVRD) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | $271.16M | $247.06M | $45.10M | $27.00M | $43.83M |
| Cash & equivalents | $31.68M | $13.45M | $21.49M | $22.92M | $37.90M |
| Current assets | $195.06M | $173.29M | $44.11M | $26.16M | $43.83M |
| Total liabilities | $22.16M | $19.53M | $90.15M | $89.06M | $48.42M |
| Current liabilities | $18.48M | $17.62M | $4.28M | $3.28M | $3.97M |
| Long-term debt | — | — | — | — | — |
| Shareholder equity | $249.00M | $227.52M | $-45.05M | $-62.06M | $-4.59M |
| Retained earnings | $-392.32M | $-480.76M | $-45.49M | $-62.84M | $-755.61M |
| Accounts receivable | $2.06M | $1.15M | $4.45M | $4.02M | $4.50M |
| Inventory | — | $2.58M | — | — | $900000.00 |
| Goodwill | — | — | — | — | — |